Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
The Pharma Letter15h
FDA nod at last for Supernus’ Parkinson’s infusion therapy
It is fourth time lucky for Supernus Pharmaceuticals, as its Parkinson’s specialist finally receives US approval for Onapgo ...
Supernus Pharmaceuticals exec sells shares worth $376,236
Padmanabh P. Bhatt, Senior Vice President of Intellectual Property and Chief Scientific Officer at Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a company that InvestingPro data shows maintains ...
Google unveils new affordable AI models
Alphabet’s Google has launched a new class of AI models within its Gemini family, introducing a cost-effective alternative to ...
The Pharma Letter4h
Positive results for Qlaris Bio’s eye drug QLS-111
US clinical-stage biotech Qlaris Bio has announced positive top-line results from two U.S. Phase II clinical trials ...
Super Micro Stock Is Rising Again. Why Optimism Is Building.
Super Micro Computer stock was rising ahead of Thursday’s opening bell, putting the artificial intelligence server maker on course for further gains. It’s finally giving investors reason to feel ...
California Healthline23h
California Healthline Daily Edition
The results were presented at the 2025 American Society of Clinical Oncology Gastrointestinal Cancers Symposium held in San Francisco late last month. They were also published in the Journal of ...